Literature DB >> 11707282

A PKCbeta isoform mediates phorbol ester-induced activation of Erk1/2 and expression of neuronal differentiation genes in neuroblastoma cells.

U Trollér1, R Zeidman, K Svensson, C Larsson.   

Abstract

Protein kinase C (PKC) activation induces neuronal differentiation of SH-SY5Y neuroblastoma cells. This study examines the role of PKCbeta isoforms in this process. The PKCbeta-specific inhibitor LY379196 had no effect on 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced neurite outgrowth from SH-SY5Y neuroblastoma cells. On the other hand, PKCbeta inhibition suppressed the TPA-stimulated increase in neuropeptide Y mRNA, activation of neuropeptide Y gene promoter elements, and phosphorylation of Erk1/2. The TPA-induced increase in neuropeptide Y expression was also inhibited by the MEK inhibitor PD98059. These data indicate that activation of a PKCbeta isoform, through a pathway involving Erk1/2, leads to increased expression of neuronal differentiation genes in neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707282     DOI: 10.1016/s0014-5793(01)03043-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats.

Authors:  Backil Sung; Grewo Lim; Jianren Mao
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.

Authors:  Matthew R Farren; Louise M Carlson; Colleen S Netherby; Inna Lindner; Pui-Kai Li; Dmitry I Gabrilovich; Scott I Abrams; Kelvin P Lee
Journal:  Sci Signal       Date:  2014-02-18       Impact factor: 8.192

3.  Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.

Authors:  Karen Bräutigam; Dirk Olaf Bauerschlag; Marion Tina Weigel; Julia Biernath-Wüpping; Thomas Bauknecht; Norbert Arnold; Nicolai Maass; Ivo Meinhold-Heerlein
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

4.  PKCbeta regulates ischemia/reperfusion injury in the lung.

Authors:  Tomoyuki Fujita; Tomohiro Asai; Martin Andrassy; David M Stern; David J Pinsky; Yu Shan Zou; Morihito Okada; Yoshifumi Naka; Ann Marie Schmidt; Shi-Fang Yan
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

5.  Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target.

Authors:  Kun Guo; Yan Li; Xiaonan Kang; Lu Sun; Jiefeng Cui; Dongmei Gao; Yinkun Liu
Journal:  Clin Exp Metastasis       Date:  2008-12-27       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.